DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Minerva Neurosciences, Inc (NERV)
« Back to company indexNERV Chatter Timeline
Stock Ticker for NERV
Most Active Tweeters for NERV
| User | Tweets |
|---|---|
| @Tickeron | 9 |
| @FonsieTrader | 5 |
| @TopStockAlerts1 | 5 |
| @AmericanBanking | 5 |
| @gcassidy718 | 5 |
Recent Tweets for NERV
 |
@Gambiste1 RT @biotechw2019: $NERV double inside days with strong ADX https://t.co/W81yIJZdjk November 10th 2019, 2:11pm |
 |
@biotechw2019 $NERV double inside days with strong ADX https://t.co/W81yIJZdjk November 10th 2019, 2:11pm |
 |
@DataTrials $NERV Phase 2 A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disord… https://t.co/D5BYTAezKW November 9th 2019, 6:11pm |
 |
@Tickeron $NERV's price moved below its 50-day Moving Average on October 1, 2019. View odds for this and other indicators:… https://t.co/bt6ORNf0mW November 8th 2019, 3:11am |
 |
@dailypoliticaln William Blair Brokers Lower Earnings Estimates for Minerva Neurosciences Inc $NERV https://t.co/SgK31m20Y6 November 8th 2019, 1:11am |
 |
@TickerReport William Blair Brokers Lower Earnings Estimates for Minerva Neurosciences Inc $NERV https://t.co/50qs3clYWS November 8th 2019, 1:11am |
 |
@TradeFlags TD SELL $NERV at 5.23, Supp 4.08 Resis 5.23 R28 HiLo 19% T1Y 19 buy 1.6 fwdPE -3.3 DIV N/A #Minerva Ne #stocks… https://t.co/g1MeOyv9EE November 7th 2019, 8:11pm |
 |
@TranscriptDaily Minerva Neurosciences $NERV Issues Earnings Results, Beats Expectations By $0.01 EPS https://t.co/fFUqziDxOQ November 7th 2019, 12:11pm |
 |
@stocknewstimes Minerva Neurosciences $NERV Announces Earnings Results https://t.co/Li9vDNLhz5 November 7th 2019, 12:11pm |
|
@TranscriptDaily Brokers Set Expectations for Minerva Neurosciences Inc’s FY2023 Earnings $NERV https://t.co/arQ6HVlb9z November 7th 2019, 5:11am |
 |
@ThisLincolnian Brokers Set Expectations for Minerva Neurosciences Inc’s FY2023 Earnings $NERV https://t.co/9cEsN8crAq November 7th 2019, 5:11am |
|
@Tickeron $NERV in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 16, 2019. View odds for thi… https://t.co/vxjEciRikZ November 7th 2019, 3:11am |
 |
@WatchlistN Q3 2019 EPS Estimates for Minerva Neurosciences Inc Lowered by Analyst $NERV https://t.co/w1xXcb1IC7 November 7th 2019, 1:11am |
 |
@fm23 $NERV https://t.co/INEDpu2Piz November 6th 2019, 6:11pm |
 |
@commander_x09 RT @semodough: JEFF $NERV roluperidone ph 3 study recruitment is back on track to expected levels with topline readout still for H1 '20. Fo… November 6th 2019, 4:11pm |
 |
@gcassidy718 $NERV I'll have my bear burger medium rare with mushroom and swiss please. 4.91 % change recently https://t.co/0qOVKeUGMi November 6th 2019, 1:11pm |
 |
@semodough JEFF $NERV roluperidone ph 3 study recruitment is back on track to expected levels with topline readout still for H… https://t.co/pd7HwUwzub November 6th 2019, 12:11pm |
 |
@76enz $NERV 7% November 6th 2019, 12:11pm |
 |
@BradWil80945247 Do you have the $NERV it takes to make it as a trader? #TradeIdeas people do! [email protected] [email protected] .… https://t.co/q9ACPUZSKe November 6th 2019, 11:11am |
 |
@dispatchtribune Minerva Neurosciences $NERV Releases Earnings Results, Beats Expectations By $0.01 EPS https://t.co/KiHCSyTSKz November 6th 2019, 11:11am |
 |
@bhtrade $NERV Still grinding upwards and starting to make its way into the gap https://t.co/P9M2sy051n November 6th 2019, 10:11am |
|
@stocknewstimes Minerva Neurosciences Inc $NERV to Post Q3 2019 Earnings of -$0.36 Per Share, William Blair Forecasts https://t.co/R9kWGSjm9N November 6th 2019, 6:11am |
 |
@TheMarketsDaily Minerva Neurosciences Inc $NERV to Post Q3 2019 Earnings of -$0.36 Per Share, William Blair Forecasts https://t.co/jE8Z3APT52 November 6th 2019, 6:11am |
 |
@AmericanBanking Minerva Neurosciences Inc $NERV to Post Q3 2019 Earnings of -$0.36 Per Share, William Blair Forecasts https://t.co/NS1zMKEGsC #stocks November 6th 2019, 6:11am |
 |
@WeekHerald Minerva Neurosciences Inc $NERV to Post FY2023 Earnings of $0.39 Per Share, William Blair Forecasts https://t.co/8QnOdOuOQl November 6th 2019, 6:11am |
|
@Tickeron $NERV in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 16, 2019. View odds for thi… https://t.co/Sm9D7R6f0c November 6th 2019, 3:11am |
|
@TickerReport Minerva Neurosciences $NERV Stock Price Up 5.2% Following Better-Than-Expected Earnings https://t.co/ITmH44OxHH November 6th 2019, 1:11am |
|
@dailypoliticaln Minerva Neurosciences $NERV Trading Up 5.2% After Strong Earnings https://t.co/lULlRDQCez November 6th 2019, 1:11am |
 |
@BlueBioNow $NERV My valuations is at $5.22. Waiting for it to come down. https://t.co/NoVetk0r28 November 6th 2019, 12:11am |
|
@TickerReport Minerva Neurosciences $NERV Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS https://t.co/MVZQ8ZNyi9 November 5th 2019, 2:11pm |
|
@dailypoliticaln Minerva Neurosciences $NERV Releases Earnings Results, Beats Estimates By $0.01 EPS https://t.co/mlotJkDyWz November 5th 2019, 2:11pm |
 |
@bbnsnews Minerva Neurosciences $NERV Issues Earnings Results https://t.co/CajlMw4Gok November 5th 2019, 1:11pm |
 |
@ConsumerFeed Minerva Neurosciences $NERV Issues Earnings Results https://t.co/BOCPTAj0Qm November 5th 2019, 1:11pm |
|
@AmericanBanking Minerva Neurosciences $NERV Issues Quarterly Earnings Results https://t.co/GpuCdUrHIf #stocks November 5th 2019, 12:11pm |
|
@76enz $NERV 6% November 5th 2019, 11:11am |
 |
@medtechy Minerva Neurosciences Reports Third Quarter 2019 Financial Results and Business Updates $NERV | https://t.co/TU8Dbsos0f November 5th 2019, 10:11am |
 |
@OlympiaReport William Blair Equities Analysts Cut Earnings Estimates for Minerva Neurosciences Inc $NERV https://t.co/pwe1AxVeV0 November 5th 2019, 10:11am |
|
@dispatchtribune William Blair Equities Analysts Cut Earnings Estimates for Minerva Neurosciences Inc $NERV https://t.co/vMBoGpILzU November 5th 2019, 9:11am |
|
@Tickeron $NERV in Uptrend: Stochastic indicator is remaining in overbought zone for 2 days. View odds for this and other ind… https://t.co/0nNRvSrygy November 5th 2019, 2:11am |
|
@gcassidy718 $NERV price movement 3.25 % https://t.co/0qOVKeUGMi November 4th 2019, 2:11pm |
 |
@SiteFocusHQ $NERV Earnings Intelligence Analysis of recent earnings identified Minerva Neurosciences (NASDAQ: NERV ) business f… https://t.co/H14RoFuTIF November 4th 2019, 2:11pm |
 |
@StockNewsWires $NERV: Minerva Neurosciences, Inc. (NERV) CEO Remy Luthringer on Q3 …: https://t.co/Yf1E99IkEG November 4th 2019, 2:11pm |
 |
@SeekingAlpha $NERV - Minerva Neurosciences, Inc. (NERV) CEO Remy Luthringer on Q3 2019 Results - Earnings Call Transcript. Read… https://t.co/qxBbTqVMjL November 4th 2019, 2:11pm |
 |
@ni_czar RT @BioStocks: $NERV topline data from Phase 2b trial of MIN-117 in adult patients with moderate or severe major depressive disorder (MDD)… November 4th 2019, 9:11am |
 |
@BioStocks $NERV topline data from Phase 2b trial of MIN-117 in adult patients with moderate or severe major depressive disord… https://t.co/HZskgKV5aK November 4th 2019, 9:11am |
|
@gcassidy718 $NERV waiting for the turn around . . . -2.53 % change recently https://t.co/0qOVKeUGMi November 4th 2019, 8:11am |
 |
@Stock_News_Now $NERV: New SEC Filing for NERV: Form 10-Q (No. 0001564590-19-039496): https://t.co/gfwh3YFY1D November 4th 2019, 8:11am |
 |
@newsfilterio Minerva Neurosciences EPS in-line $NERV https://t.co/p92wamDqLK November 4th 2019, 7:11am |
 |
@JennyMillan7 RT @MarketCurrents: $NERV - Minerva Neurosciences EPS in-line https://t.co/KMvyMYM14W November 4th 2019, 7:11am |
|
@semodough $NERV Minerva Neurosciences Reports Third Quarter 2019 Financial Results and Business Updates | MINERVA NEUROSCIENC… https://t.co/wYLr4cy7TH November 4th 2019, 7:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.